Addus HomeCare (NASDAQ:ADUS) Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Addus HomeCare (NASDAQ:ADUS) issued its earnings results on Monday. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09), Zacks reports. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%.

Addus HomeCare Trading Down 0.4 %

Shares of ADUS opened at $108.84 on Tuesday. The business’s fifty day simple moving average is $124.60 and its two-hundred day simple moving average is $126.69. Addus HomeCare has a 12 month low of $85.94 and a 12 month high of $136.72. The company has a market cap of $1.97 billion, a price-to-earnings ratio of 24.91, a P/E/G ratio of 1.41 and a beta of 1.00.

Wall Street Analysts Forecast Growth

ADUS has been the subject of several research reports. JMP Securities initiated coverage on Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price for the company. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Finally, Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $134.22.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.